Treatment for recurrent viral hepatitis after liver transplantation

Journal of Hepatology

Volumn 26, Issue 2, 1997, Pages 440-445

  Brumage, Lynne K ^a   Wright, Teresa L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FAMCICLOVIR; IMMUNOGLOBULIN; LAMIVUDINE;

ARTICLE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; VIRUS HEPATITIS;

EID: 0031039775     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80066-9     Document Type: Article

References (19)

1. Detre K. Liver transplantation for chornic viral hepatitis. 1995;A.A.S.L.D. Single Topic Conference, Reston, Va, USA.
2. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. The Investigators of the European Concerted Action on Viral Hepatitis Study. Live transplantation in European patients with the hepatitis B surface antigen. N Engl J Med. 329:1993;1842-1847.
3. Todo S, Demetris AJ, Van Thiel DH, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology. 13:1991;619-626.
4. Angus PW, Locarnini SA, McCaughen GW, Jones RM, McMillan JS, Bowden DS. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology. 21:1995;14-18.
5. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using schedule of hepatitis B immunoglobulin. Hepatology. 24:1996;1327-1333.
6. Marcellin P, Samuel D, Areias J, et al. Pre-transplantation interferon treatment and recurrence of hepatitis B virus infection after live transplantation for hepatitis B-related endstage liver disease. Hepatology. 19:1994;6-12.
7. Grellier L, Brown D, McPhilips P, Burroughs A, Rolles K, Dushieko G. Lamivudine prophylaxis: a new strategy for prevention of reinfection in liver transplantation for hepatitis B DNA positive cirrhosis. Hepatology. 22:1995;224A.
8. Terrault NA, Holland C, Ferrell L, Hahn JA, Lake JR, Roberts J, Ascher NL, Wright TL. Interferon alpha for recurrent hepatitis B infection following liver transplantation. Liver Transplant Surg. 2:1996;132-138.
9. Gish RG, Johnson YNL, Brooks, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology. 23:1996;1-7.
10. Bartholomew M, Vicary C, Roach K, Jeffers LJ, Bernstein D, de Medina M, et al. Use of lamivudine in the treatment of recurrent hepatitis B infection post-liver transplantation. Gastroenterology. 108:1995;A1030.
11. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 103:1992;317-322.
12. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhioll JA, Donaldson PT, Maertens G, Williams R. Long term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 334:1996;815-820.
13. Donegan E, Wright TL, Roberts J, Ascher NL, Lake JR, Neuwald P, Wilber J, Quan S, Kuramoto K, Dinello RK, Urdea M. Detection of hepatitis C after liver transplantation: four serologic tests compared. Am J Clin Pathol. 104:1995;673-679.
14. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, Okamoto H, Bismuth H, Brechot C. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology. 108:1995;1088-1096.
15. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JN, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of disease in liver transplant recipients with hepatitis C virus infection: relationship to genotype and level of viermia. Hepatology. 24:1996;1041-1046.
16. Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, Roberts J, Wilber J, Sheridan P, Urdea M. Interferonalpha therapy for hepatitis C virus infection after liver transplantation. Hepatology. 20:1994;773-779.
17. Feray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reynes M, et al. An open trial of interferon alpha recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology. 22:1995;1084-1089.
18. Bisceglie AMD, Conjeevaram HS, Fried MW, et al. Ribavirin as therapy for chronic hepatitis C. Ann Intern Med. 123:1995;897-903.
19. Cattral MS, Krajden M, Wanless IR, Rezig M, Cameron R, Greig PH, Chung SW, Levy GA. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation. 61:1996;1483-1488.